Assenagon Asset Management
XENT

Assenagon Asset Management’s Intersect ENT, Inc XENT Stock Holding History

Assenagon Asset Management’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-212,401
Closed -$3.63M – 1476
2021
Q2 		$3.63M Buy
212,401
+6,589
+3% +$123K 0.01% 554
2021
Q1 		$4.3M Sell
205,812
-18
-0% -$415 0.02% 544
2020
Q4 		$4.71M Sell
205,830
-197,914
-49% -$3.77M 0.02% 362
2020
Q3 		$6.58M Buy
403,744
+145,382
+56% +$2.63M 0.04% 270
2020
Q2 		$3.5M Buy
+258,362
New +$3.01M 0.02% 421
2019
Q4 		– Sell
-129,428
Closed -$2.2M – 1000
2019
Q3 		$2.2M Buy
+129,428
New +$2.36M 0.01% 388
2018
Q2 		– Sell
-32,127
Closed -$1.26M – 624
2018
Q1 		$1.26M Buy
+32,127
New +$1.17M 0.02% 369

Other funds holding XENT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Assenagon Asset Management's XENT Position: Q3 2021 in Review

Assenagon Asset Management sold out of Intersect ENT, Inc (XENT) in Q3 2021, closing a stake of 212,401 shares — an estimated $3.63M sold.

Assenagon Asset Management first reported a position in XENT in Q1 2018 and held it in 7 quarters. The position peaked at $6.58M in Q3 2020. 123 funds tracked by Wall St. Rank hold XENT as of Q3 2021.

  • Assenagon Asset Management reported no remaining Intersect ENT, Inc position as of Q3 2021 after selling out during the quarter.
  • Assenagon Asset Management sold 212,401 Intersect ENT, Inc shares in Q3 2021, an estimated $3.63M.
  • Assenagon Asset Management first reported a position in Intersect ENT, Inc in Q1 2018 and held it in 7 quarters.
  • Assenagon Asset Management's Intersect ENT, Inc position peaked at $6.58M in Q3 2020.
  • 123 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2021.

Based on Assenagon Asset Management's 13F filing for Q3 2021, filed 19 Oct 2021.